why Lyra Therapeutics Inc [LYRA] is a Good Choice for Investors After New Price Target of $2.00
Lyra Therapeutics Inc [NASDAQ: LYRA] gained 2.94% or 0.0 points to close at $0.10 with a heavy trading volume of 27130976 shares. The daily chart for LYRA points out that the company has recorded -59.44% loss over the past six months. If we look at